Skip to main content
. Author manuscript; available in PMC: 2023 Sep 12.
Published in final edited form as: Clin Neuropsychol. 2021 Jul 5;36(2):327–352. doi: 10.1080/13854046.2021.1940299

Table 3.

T-tests and Chi Squares Among Study Variables and Conversion to Alzheimer’s Disease (AD)

Men (N=1744)
% Diagnosed with AD Statistic
Race Black White χ2(1, 1337) =2.44, p=.12
31.5% 30.9%
APOE e4 allele Absent Present χ2(1, 1251) =46.90, p<.001
23.2% 41.6%
Hypertension Absent Present χ2(1, 1337) =1.25, p=.26
29.1% 32.0%
Diabetes Absent Present χ2(1,1337) =4.12, p=.04
29.8% 37.1%
Referral Source Non-professional Professional χ2(1,1337) =88.62, p<.001
22.3% 47.3%
Years of Education No AD
M=16.76, SD=4.82
AD
M=16.65, SD=7.69
t(1335)=.32, p=.75
Women (N=2592)
Descriptive Data Statistic
Race Black White χ2(1, 2367) =1.45, p=.23
18.6% 21.3%
APOE e4 allele Absent Present χ2(1, 2200) =61.34, p<.001
15.5% 29.7%
Hypertension Absent Present χ2(1, 2367) =23.24, p<.001
16% 24.2%
Diabetes Absent Present χ2(1, 2367) =.30, p=.58
20.7% 22.1%
Referral Source Professional Non-professional χ2(1, 2367) =73.19, p<.001
16.7% 33.2%
Years of Education No AD
M=15.95, SD=5.84
AD
M=15.44, SD=7.16
t(2365)=1.63, p=.10